Croma-Pharma
Odile Jean is an experienced professional in regulatory affairs and research and development, currently serving as an Expert Regulatory Affairs at Croma-Pharma since June 2023. Previously held positions include Junior Regulatory Affairs Manager at Rembrandtin Lack Ges.m.b.H. and R&D Engineer, as well as R&D Intern roles at tesa and Trinseo Deutschland Anlagengesellschaft mbH, focusing on the development of emulsions and resins for various applications. Odile's early career included an internship in academic research at Institut Européen des Membranes, contributing to PhD work on advanced materials, and a secretarial role in student government at BDE ENSCM. Educational background includes a degree from Ecole Nationale Supérieure de Chimie de Montpellier, further studies at Technische Universität Wien, and completion of baccalaureate at Lycée Jean-Baptiste Kléber and Lycée Condorcet.
This person is not in any offices
Croma-Pharma
4 followers
Croma is a global player in the minimally invasive aesthetics market and a leading European manufacturer of premium quality hyaluronic acid syringes. The company offers a comprehensive and innovative aesthetics portfolio including botulinum toxin, fillers, lifting threads and biostimulators complemented by its own skincare brand. Founded in 1976 by a pharmacist couple, Croma-Pharma GmbH is a family company headquartered in Austria where it also operates its manufacturing plant. With 550 employees, 13 subsidiaries in Europe and Brazil, two joint ventures and 60 exclusive export partners, it distributes its products in 80 markets globally, including the US, Canada, China, Australia and New Zealand. It also operates as a contract manufacturer in orthopaedics and ophthalmology. For more information please visit cromapharma.com.